Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children

No To Hattatsu

Volumn 34, Issue 3, 2002, Pages 249-253

  Yokoyama, Hiroyuki ^a   Hirose, Mieko ^a   Haginoya, Kazuhiro ^a   Munakata, Mitsutoshi ^a   Iinuma, Kazuie ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TANDOSPIRONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADOLESCENT; AGGRESSION; AUTISM; AUTOMUTILATION; BEHAVIOR THERAPY; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DROWSINESS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; MALE; PSYCHOTHERAPY;

AGGRESSION; AUTISTIC DISORDER; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; FLUVOXAMINE; HUMANS; MALE; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS;

EID: 0036251443     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder
2. New evidence for neurotransmitter influences on brain development
3. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children
4. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
5. Effects of fluoxetine treatment in young children with idiopathic autism
6. Psychopharmacology
7. SSRI safety in overdose
8. Life-threatening fluvoxamine over-dose in a 4-year-old child
9. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases
10. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression